Cargando…

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning

PURPOSE: To evaluate the response to and dependence on aflibercept or ranibizumab in patients with age-related macular degeneration (AMD). METHODS: We retrospectively reviewed AMD patients who received induction therapy with aflibercept or ranibizumab for the following parameters: whether complete r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Noriko, Mandai, Michiko, Kojima, Hiroshi, Kameda, Takanori, Shimozono, Masataka, Nishida, Akihiro, Kurimoto, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417657/ https://www.ncbi.nlm.nih.gov/pubmed/28496299 http://dx.doi.org/10.2147/OPTH.S133332

Ejemplares similares

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
por: Nishida, Akihiro, et al.
Publicado: (2017)

Incidence of outer retinal tubulation in eyes with choroidal neovascularization under intravitreal anti-vascular endothelial growth factor therapy in a Japanese population
por: Takagi, Seiji, et al.
Publicado: (2017)

Automated evaluation of retinal pigment epithelium disease area in eyes with age-related macular degeneration
por: Motozawa, Naohiro, et al.
Publicado: (2022)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration
por: Sugita, Sunao, et al.
Publicado: (2020)

Trends of Stem Cell Therapies in Age-Related Macular Degeneration
por: Maeda, Tadao, et al.
Publicado: (2021)

Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
por: Isildak, Hacer, et al.
Publicado: (2018)

Possible vitreous involvement in a case with rapidly progressing choroidal neovascularization
por: Hata, Masayuki, et al.
Publicado: (2012)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium
por: Matsuzaki, Mitsuhiro, et al.
Publicado: (2020)

Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
por: Menteş, Jale, et al.
Publicado: (2022)

Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration
por: Kanemura, Hoshimi, et al.
Publicado: (2014)

Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
por: Arai, Yusuke, et al.
Publicado: (2020)

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2012)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Application and mechanism of anti-VEGF drugs in age-related macular degeneration
por: Song, Dawei, et al.
Publicado: (2022)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration
por: Suzuki, Mihoko, et al.
Publicado: (2007)

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
por: Balikova, Irina, et al.
Publicado: (2019)

Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes
por: William, Antony, et al.
Publicado: (2023)

Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa
por: Kuroda, Masako, et al.
Publicado: (2014)

VEGFA Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration
por: Vilkeviciute, Alvita, et al.
Publicado: (2022)

Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
por: Sato, Tomohito, et al.
Publicado: (2018)

Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
por: Senra, Hugo, et al.
Publicado: (2016)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)

Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment
por: Oca, Ana I., et al.
Publicado: (2021)

Smooth pursuit eye movements in patients with macular degeneration
por: Shanidze, Natela, et al.
Publicado: (2016)

Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases
por: Khoo, Hock Eng, et al.
Publicado: (2019)

Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes
por: Wichrowska, Małgorzata, et al.
Publicado: (2022)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou, Stamatina A, et al.
Publicado: (2017)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

Refractory Age-Related Macular Degeneration Due to Concurrent Central Serous Chorioretinopathy in Previously Well-Controlled Eyes
por: Hara, Chikako, et al.
Publicado: (2023)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration
por: Miyata, Manabu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvkhtan15o4scbkigqfn1du8lc